IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,662 | +88.1% | 585 | +191.0% | 0.00% | – |
| Q2 2023 | $1,415 | -1.9% | 201 | -14.8% | 0.00% | – |
| Q1 2023 | $1,442 | +2.6% | 236 | +7.3% | 0.00% | – |
| Q4 2022 | $1,406 | -71.9% | 220 | -59.0% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 536 | +5.1% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 510 | +97.7% | 0.00% | – |
| Q1 2022 | $4,000 | -66.7% | 258 | -60.5% | 0.00% | – |
| Q4 2021 | $12,000 | -29.4% | 653 | -5.4% | 0.00% | -100.0% |
| Q3 2021 | $17,000 | +88.9% | 690 | +93.8% | 0.00% | – |
| Q2 2021 | $9,000 | +200.0% | 356 | +350.6% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 79 | +75.6% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 45 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 45 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |